Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2002
11/12/2002CA2088289C Pharmaceutically active composition extracted from tanacetum parthenium, process for its extraction, and pharmaceutical composition containing same
11/12/2002CA2018564C 4,5,5a,6-tetrahydro-3h-isoxazolo¬5,4,3-kl|acridines derivatives, a process for their preparation and their use as medicaments
11/11/2002CA2385692A1 Thiazole derivatives
11/11/2002CA2347879A1 Substituted dicinnamoylquinides and their use in augmentation of adenosine function
11/07/2002WO2002088664A2 Control of compactability through crystallization
11/07/2002WO2002088354A1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use
11/07/2002WO2002088330A2 Neural progenitor cells
11/07/2002WO2002088317A2 Fusion molecules and methods for treatment of immune diseases
11/07/2002WO2002088316A2 G-protein coupled receptors
11/07/2002WO2002088182A1 Nove g protein-coupled receptor protein and dna thereof
11/07/2002WO2002088159A1 Pharmaceutically active uridine esters
11/07/2002WO2002088146A2 ANTIDEPRESSANT INDOLETETRAHYDROPYRIDINE DERIVATIVES OF 2,3-DIHYDRO-7H-[1,4]DIOXINO[2,3-e]INDOLE
11/07/2002WO2002088145A1 AZABICYCLYLMETHYL DERIVATIVES OF 7,8-DIHYDRO-1,6,9-TRIOXA-3-AZACYCLOPENTA[a]NAPHTHALENE AS 5-HT1A ANTAGONISTS
11/07/2002WO2002088144A2 ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO[2,3-f]QUINOXALINE
11/07/2002WO2002088143A2 Dihydroimidazo[4,5-e]indole and 7h-pyrrolo[3,2-f]quinoxaline derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands
11/07/2002WO2002088142A1 ANTIPSYCHOTIC AMINOMETHYL DERIVATIVES OF 7,8-DIHYDRO-3H-1,6,9-TRIOXA-3-AZA-CYCLOPENTA[a]NAPHTHALEN-2-ONE
11/07/2002WO2002088141A2 ANTIPSYCHOTIC AMINOMETHYL DERIVATIVES OF 7,8-DIHYDRO-2,6,9-TRIOXA-3-AZA-CYCLOPENTA[a]NAPHTHALENE
11/07/2002WO2002088140A1 Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta[a]naphthalene
11/07/2002WO2002088139A1 6h-oxazolo[4,5-e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands
11/07/2002WO2002088138A1 Novel 4-amino-5,6-substituted thiopheno[2,3-d]pyrimidines
11/07/2002WO2002088137A1 Pkb-3564 substance with neovascularization inhibitory activity
11/07/2002WO2002088136A2 Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene
11/07/2002WO2002088135A1 Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused-[1,4]-benzodioxans
11/07/2002WO2002088134A2 Antipsychotic aminomethyl derivatives of 1,3,7,8-tetrahydro-6,9-dioxa-1,3-diaza-cyclopenta[a]-naphthalen-2-one
11/07/2002WO2002088133A1 ANTIPSYCHOTIC AMINOMETHYL DERIVATIVES OF 7,8-DIHYDRO-3H-6,9-DIOXA-2,3-DIAZA-CYCLOPENTA[a]NAPHTHALENE
11/07/2002WO2002088132A1 Azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinoline as 5-ht1aantagonists
11/07/2002WO2002088131A1 Antidepressant (sssri) azaheterocyclymethyl derivatives of 7,8-dihydro-3h-t,9-dioxa-1,3-diazacyclopenta[a]naphthalene
11/07/2002WO2002088130A1 Azabicyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino-[2,3-f]quinoline as 5-ht1a antagonists
11/07/2002WO2002088129A1 Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinazoline
11/07/2002WO2002088122A1 Heterocyclic compounds
11/07/2002WO2002088121A1 Pyrazolo[1,5-a]pyridines and medicines containing the same
11/07/2002WO2002088118A1 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists
11/07/2002WO2002088114A2 Heteroaryl ofefinic azacyclic and heteroaryl acetylenic azacyclic compounds for the treatment of cns disorders
11/07/2002WO2002088101A2 Inhibitors of bace
11/07/2002WO2002088100A2 Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
11/07/2002WO2002088097A1 Triazole-derived kinase inhibitors and uses thereof
11/07/2002WO2002088096A1 Compounds inhibiting cyclic nucleotide phosphodiesterases, preparation and uses thereof
11/07/2002WO2002088095A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
11/07/2002WO2002088094A1 2-iminoimidazole derivatives (1)
11/07/2002WO2002088093A1 Benzimidazoles that are useful in treating sexual dysfunction
11/07/2002WO2002088092A1 2-iminoimidazole derivative (2)
11/07/2002WO2002088090A2 Pyrazole derived kinase inhibitors
11/07/2002WO2002088089A1 Spiropiperidine derivatives, nociceptin receptor antagonists containing the same as the active ingredient and medicinal compositions
11/07/2002WO2002088087A1 Novel heterocyclic derivatives
11/07/2002WO2002088080A2 Dual inhibitors of pde 7 and pde 4
11/07/2002WO2002088079A2 Dual inhibitors of pde 7 and pde 4
11/07/2002WO2002088078A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3β PROTEIN AND PROTEIN COMPLEXES
11/07/2002WO2002087747A1 Stable aqueous colloidal dispersion, method for preparing same
11/07/2002WO2002087626A1 Pharmaceutical compositions comprising dendritic cells for immunotherapy of autoimmune disease and treatment methods using the same
11/07/2002WO2002087608A1 Novel pain relievers which are trp-channel inhibitors
11/07/2002WO2002087604A2 Preparations containing a combination of vitamin e and afamin
11/07/2002WO2002087593A1 A method for treating or preventing a functional vitamin b12 deficiency in an individual and to medical compositions for use in said method
11/07/2002WO2002087590A1 Treatment of psychotic disorders comprising co-therapy with anticonvulsant derivatives and atypical antipsychotics
11/07/2002WO2002087582A1 Use of the opioid antagonist naltrexone to prevent and control side effects caused by opioids
11/07/2002WO2002087573A1 Crf receptor antagonists
11/07/2002WO2002087569A1 Bisarylimidazolyl fatty acid amide hydrolase inhibitors
11/07/2002WO2002087566A1 The use of enantiomeric pure escitalopram
11/07/2002WO2002087562A1 Use of protein and essential amino acids to treat amenorrhea and related disorders
11/07/2002WO2002087559A1 Potassium channel opener
11/07/2002WO2002087558A1 Pharmaceutical composition which reduces or eliminates drug abuse potential
11/07/2002WO2002087553A2 Use of desoxypeganine for treating central nervous system symptoms resulting from intoxications by psychotrops
11/07/2002WO2002087552A2 Androgen-mediated neuroprotection and uses thereof
11/07/2002WO2002087548A1 A pharmaceutical tablet having a high api content
11/07/2002WO2002087513A2 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7
11/07/2002WO2002087512A2 Once-a-day oxycodone formulations
11/07/2002WO2002087496A2 Methods for inhibiting macrophage colony stimulating factor and c-fms-dependent cell signaling
11/07/2002WO2002087465A2 Compositions and methods of double-targeting virus infections and cancer cells
11/07/2002WO2002087424A2 Treatment and diagnosis of macrophage mediated disease
11/07/2002WO2002087423A2 Carbonic anhydrase activators for enhancing learning and memory
11/07/2002WO2002067955A3 A process for the manufacture of a herbal composition comprising a matrine
11/07/2002WO2002066026A3 Tramadol-based medicament
11/07/2002WO2002064546A3 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/07/2002WO2002056827A3 Substituted felbamate derived compounds
11/07/2002WO2002044141A3 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
11/07/2002WO2002040649A8 Slo2 and slo4, novel potassium channel proteins from human brain
11/07/2002WO2002028897A3 Human g-protein coupled receptor and uses thereof
11/07/2002WO2002009768A3 Therapeutic polyesters and polyamides
11/07/2002WO2002009767A3 Therapeutic polyanhydride compounds for drug delivery
11/07/2002WO2002002600A3 HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR27, AND USES THEROF
11/07/2002WO2001093888A3 A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs
11/07/2002WO2001085687A1 Substituted indoles as parp inhibitors
11/07/2002WO2001047866A9 Substituted 1 and 2 naphthol mannich bases
11/07/2002WO2001042784A9 Methods for screening compounds active on neurons
11/07/2002WO2001034586A3 Branched adamantyl and noradamantyl aryl- and aralkylpiperazines with serotonin 5-ht1a activity
11/07/2002WO2001027305A9 Process for producing, methods and compositions of cholesterol lowering agents from higher basidiomycetes mushrooms
11/07/2002WO2000064420A3 Compositions and methods for treating amyloidosis using sulphonate derivatives
11/07/2002US20020166132 System for regulating in vivo the expression of a transgene by conditional inhibition
11/07/2002US20020165412 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
11/07/2002US20020165395 Substituted piperidine derivatives
11/07/2002US20020165386 C-junction-n-terminal kinase (JNK); microbiocides; treating neurodegenerative diseases
11/07/2002US20020165380 A nucleic acid probe consisting a nucleic acid molecule of at least 15 nucleotides which is complementary to the antisense sequence of a unique fragment of the sequence of a nucleic acid molecule encoding a mammalian fb41 receptor
11/07/2002US20020165377 ADAM polynucleotides, polypeptides, and antibodies
11/07/2002US20020165374 Secreted protein HFEAF41
11/07/2002US20020165351 Novel compounds
11/07/2002US20020165275 Trisubstituted carbocyclic cyclophilin binding compounds and their use
11/07/2002US20020165273 Carbamate compounds for use in preventing or treating neurodegenerative disorders
11/07/2002US20020165272 Carbamate compounds for use in preventing or treating psychotic disorders
11/07/2002US20020165268 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease
11/07/2002US20020165251 Such as 1-phenylsulfonyl-4-piperazinylindole hydrochloride for treatment or prophylaxis of disease mediated by serotonin related receptor, obesity, and/or central nervous system disorder
11/07/2002US20020165247 Use of morphine derivatives as medicaments for the treatment of neuropathic problems
1 ... 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 ... 1833